DEXWireNews

Xeris Pharmaceuticals, Inc 50% upside

ロング
NASDAQ:XERS   Xeris Biopharma Holdings, Inc.
Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.

⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our Mobile App >> link-to.app/dexwirenews

2) Join our Telegram >> t.me/DEXWireNews

3) Join us on WhatsApp >> dexwirenews.com/WhatsApp

4) Follow @DEXWireNews on Social Media
免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。